Follow
Christopher Uhl
Christopher Uhl
Imvax Inc.
Verified email at alum.lehigh.edu - Homepage
Title
Cited by
Cited by
Year
Facile tumor spheroids formation in large quantity with controllable size and high uniformity
W Shi, J Kwon, Y Huang, J Tan, CG Uhl, R He, C Zhou, Y Liu
Scientific reports 8 (1), 6837, 2018
672018
Magnetic particles assisted capture and release of rare circulating tumor cells using wavy-herringbone structured microfluidic devices
W Shi, S Wang, A Maarouf, CG Uhl, R He, D Yunus, Y Liu
Lab on a Chip 17 (19), 3291-3299, 2017
512017
Mechanical response of cardiovascular stents under vascular dynamic bending
J Xu, J Yang, N Huang, C Uhl, Y Zhou, Y Liu
Biomedical engineering online 15, 1-20, 2016
482016
Microfluidic device for expedited tumor growth towards drug evaluation
CG Uhl, Y Liu
Lab on a Chip 19 (8), 1458-1470, 2019
302019
The shape effect on polymer nanoparticle transport in a blood vessel
CG Uhl, Y Gao, S Zhou, Y Liu
RSC advances 8 (15), 8089-8100, 2018
302018
Fabrication of circular microfluidic channels through grayscale dual-projection lithography
R He, D Yunus, C Uhl, W Shi, S Sohrabi, Y Liu
Microfluidics and Nanofluidics 21, 1-10, 2017
222017
Biomimetic microfluidic platform for the quantification of transient endothelial monolayer permeability and therapeutic transport under mimicked cancerous conditions
CG Uhl, VR Muzykantov, Y Liu
Biomicrofluidics 12 (1), 2018
182018
Bi-layer blood vessel mimicking microfluidic platform for antitumor drug screening based on co-culturing 3D tumor spheroids and endothelial layers
W Shi, L Reid, Y Huang, CG Uhl, R He, C Zhou, Y Liu
Biomicrofluidics 13 (4), 2019
152019
Theoretical analysis of the cooling performance of a thermoelectric element with temperature-dependent material properties
C Ju, X Wang, G Dui, CG Uhl, L Xin
Journal of Electronic Materials 48, 4627-4636, 2019
112019
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma
C Cultrara, C Uhl, K Kirby, EA Elrazaq, A Zellander, DW Andrews, ...
Journal for Immunotherapy of Cancer 11 (8), 2023
72023
Organ-on-chip devices toward applications in drug development and screening
C Uhl, W Shi, Y Liu
Journal of Medical Devices 12 (4), 040801, 2018
62018
Performance analysis of a functionally graded thermoelectric element with temperature-dependent material properties
C Ju, G Dui, CG Uhl, L Chu, X Wang, Y Liu
Journal of Electronic Materials 48, 5542-5554, 2019
52019
Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production
C Uhl, T Nyirenda, DS Siegel, WY Lee, J Zilberberg
Heliyon 8 (3), 2022
42022
Personalized immunotherapeutic platform with evidence of clinical activity in glioblastoma (IGV-001) protects mice against other lethal solid tumor challenges
J Zilberberg, A Zellander, C Uhl, C Cultrara, K Kirby, E Elazaq, CB Scott, ...
Cancer Research 82 (12_Supplement), 626-626, 2022
32022
218 Autologous glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor protect against tumor challenge and generate T cell …
J Zilberberg, A Zellander, K Kirby, C Uhl, C Cultrara, C Scott, D Andrews, ...
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021
32021
1398 Personalized immunotherapeutic platform with evidence of clinical activity in glioblastoma protects mice against ovarian liver and bladder cancer tumor challenges
A Zellander, C Uhl, C Cultrara, K Kirby, E Elrazaq, C Scott, D Andrews, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
22022
ROS-Dependent Activation of Immunogenic Glioblastoma Cell Death and Release of Immunogenic Particles by an Autologous Cell-Based Immunotherapeutic Platform
C Cultrara, K Kirby, E Elrazaq, C Uhl, A Zellander, L Galluzzi, M Exley, ...
Cancer Research 83 (7_Supplement), 1812-1812, 2023
2023
1071 Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes
C Cultrara, K Kirby, E Elrazaq, C Uhl, A Zellander, L Galluzzi, M Exley, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2022
Machine learning algorithm identifies key serum cytokines associated with evidence of clinical activity in patients treated with personalized immunotherapeutic platform (IGV-00)
C Uhl, J Zilberberg, CB Scott, DW Andrews, M Exley
Cancer Research 82 (12_Supplement), 2782-2782, 2022
2022
Characterizing Targeted Therapeutic Delivery and Cellular Dynamics using In Vitro Cancer Disease Models
C Uhl
Lehigh University, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20